These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 15290734)

  • 1. The clinical effect of dietary supplementation with omega-3 fish oils and/or copper in systemic lupus erythematosus.
    Duffy EM; Meenagh GK; McMillan SA; Strain JJ; Hannigan BM; Bell AL
    J Rheumatol; 2004 Aug; 31(8):1551-6. PubMed ID: 15290734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised interventional trial of omega-3-polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus.
    Wright SA; O'Prey FM; McHenry MT; Leahey WJ; Devine AB; Duffy EM; Johnston DG; Finch MB; Bell AL; McVeigh GE
    Ann Rheum Dis; 2008 Jun; 67(6):841-8. PubMed ID: 17875549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placebo-controlled randomized clinical trial of fish oil's impact on fatigue, quality of life, and disease activity in Systemic Lupus Erythematosus.
    Arriens C; Hynan LS; Lerman RH; Karp DR; Mohan C
    Nutr J; 2015 Aug; 14():82. PubMed ID: 26283629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of Omega-3 fatty acid supplementation in systemic lupus erythematosus patients: A systematic review.
    Ramessar N; Borad A; Schlesinger N
    Lupus; 2022 Mar; 31(3):287-296. PubMed ID: 35023407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction of omega-3 fatty acid deficiency and improvement in disease activity in patients with systemic lupus erythematosus treated with krill oil concentrate: a multicentre, randomised, double-blind, placebo-controlled trial.
    Salmon J; Wallace DJ; Rus V; Cox A; Dykas C; Williams B; Ding Y; Hals PA; Johnsen L; Lipsky PE
    Lupus Sci Med; 2024 Jul; 11(2):. PubMed ID: 39009356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fish oil N-3 fatty acids increase adiponectin and decrease leptin levels in patients with systemic lupus erythematosus.
    Lozovoy MA; Simão AN; Morimoto HK; Scavuzzi BM; Iriyoda TV; Reiche EM; Cecchini R; Dichi I
    Mar Drugs; 2015 Feb; 13(2):1071-83. PubMed ID: 25690094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial.
    Nogueira MA; Oliveira CP; Ferreira Alves VA; Stefano JT; Rodrigues LS; Torrinhas RS; Cogliati B; Barbeiro H; Carrilho FJ; Waitzberg DL
    Clin Nutr; 2016 Jun; 35(3):578-86. PubMed ID: 26047766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of exergame training combined with omega-3 fatty acids on the elderly brain: a randomized double-blind placebo-controlled trial.
    Schättin A; Baier C; Mai D; Klamroth-Marganska V; Herter-Aeberli I; de Bruin ED
    BMC Geriatr; 2019 Mar; 19(1):81. PubMed ID: 30866834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
    Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
    Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of melatonin supplementation on serum oxidative stress markers and disease activity in systemic lupus erythematosus patients: A randomised, double-blind, placebo-controlled trial.
    Nabatian-Asl M; Ghorbanihaghjo A; Malek Mahdavi A; Khabbazi A; Hajialilo M; Ghojazadeh M
    Int J Clin Pract; 2021 Jul; 75(7):e14246. PubMed ID: 33877728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omega-3 in SLE: a double-blind, placebo-controlled randomized clinical trial of endothelial dysfunction and disease activity in systemic lupus erythematosus.
    Bello KJ; Fang H; Fazeli P; Bolad W; Corretti M; Magder LS; Petri M
    Rheumatol Int; 2013 Nov; 33(11):2789-96. PubMed ID: 23817872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized study of the safety and efficacy of fish oil (omega-3 fatty acid) supplementation with dietary and exercise counseling for the treatment of antiretroviral therapy-associated hypertriglyceridemia.
    Wohl DA; Tien HC; Busby M; Cunningham C; Macintosh B; Napravnik S; Danan E; Donovan K; Hossenipour M; Simpson RJ
    Clin Infect Dis; 2005 Nov; 41(10):1498-504. PubMed ID: 16231263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer.
    Cerchietti LC; Navigante AH; Castro MA
    Nutr Cancer; 2007; 59(1):14-20. PubMed ID: 17927497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omega-3 fatty acid supplementation in clinical and experimental lupus nephritis.
    Clark WF; Parbtani A
    Am J Kidney Dis; 1994 May; 23(5):644-7. PubMed ID: 8172205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No effect of fish oil supplementation on serum inflammatory markers and their interrelationships: a randomized controlled trial in healthy, middle-aged individuals.
    Pot GK; Brouwer IA; Enneman A; Rijkers GT; Kampman E; Geelen A
    Eur J Clin Nutr; 2009 Nov; 63(11):1353-9. PubMed ID: 19623203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
    Young GS; Conquer JA; Thomas R
    Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omega-3 fatty acid dietary supplementation in systemic lupus erythematosus.
    Clark WF; Parbtani A; Huff MW; Reid B; Holub BJ; Falardeau P
    Kidney Int; 1989 Oct; 36(4):653-60. PubMed ID: 2811063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dietary modification and fish oil supplementation on dyslipoproteinemia in pediatric systemic lupus erythematosus.
    Ilowite NT; Copperman N; Leicht T; Kwong T; Jacobson MS
    J Rheumatol; 1995 Jul; 22(7):1347-51. PubMed ID: 7562770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary supplementation with n-3-fatty acids in patients with pancreatic cancer and cachexia: marine phospholipids versus fish oil - a randomized controlled double-blind trial.
    Werner K; Küllenberg de Gaudry D; Taylor LA; Keck T; Unger C; Hopt UT; Massing U
    Lipids Health Dis; 2017 Jun; 16(1):104. PubMed ID: 28578704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fish oil decreases the severity of treatment-related adverse events in gastrointestinal cancer patients undergoing chemotherapy: A randomized, placebo-controlled, triple-blind clinical trial.
    Camargo CQ; Mocellin MC; Brunetta HS; Chagas TR; Fabre MES; Trindade EBSM; Silva ELD; Nunes EA
    Clin Nutr ESPEN; 2019 Jun; 31():61-70. PubMed ID: 31060836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.